Atlas Trials

A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Clinical trial NCT04273815 · UNKNOWN

Trial details

NCT number
NCT04273815
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2020-07-06
Primary completion
2021-01-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.